e-learning
resources
London 2016
Tuesday, 06.09.2016
Monitoring comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
András Bikov (Budapest, Hungary), András Bikov, Orsolya Gall, Zoltan Sutto, Aniko Bohacs, Eszter Csiszer, Gyorgy Losonczy, Veronika Muller
Source:
International Congress 2016 – Monitoring comorbidities
Session:
Monitoring comorbidities
Session type:
Thematic Poster
Number:
4148
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
András Bikov (Budapest, Hungary), András Bikov, Orsolya Gall, Zoltan Sutto, Aniko Bohacs, Eszter Csiszer, Gyorgy Losonczy, Veronika Muller. Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients. Eur Respir J 2016; 48: Suppl. 60, 4148
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Related content which might interest you:
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Heterogeneity within chronic lung allograft dysfunction: A BAL analysis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Immediate post-operative bronchoalveolar neutrophilia is associated with FEV
1
early after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Bronchoalveolar lavage in children with diffuse lung disease
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008
Aberrant metalloprotease expression and activity in bronchoalveolar lavage fluid of bronchiolitis obliterans patients
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept